Factors influencing the decision to vaccinate against Covid-19 and seasonal influenza in adults with and without depression/anxiety in primary care
- Conditions
- bronchial asthma, COPD, type 1/2 diabetes mellitus, coronary artery disease or breast cancerdepressionanxiety disorder
- Registration Number
- DRKS00030042
- Lead Sponsor
- Friedrich-Baur-Stiftung, LMU Klinikum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 803
Inclusion Criteria
Patient must meet the so-called M2Q criterion (at least 2 quarters) coding for outpatient treatment must be done twice in different quarters, vaccination documentation available (patient management software or vaccination book), patients suffer from at least one of the following chronic somatic diseases: Asthma, Chronic obstructive pulmonary disease (COPD), breast cancer, coronary artery disease (CHD) or diabetes mellitus type 1 and 2.
Exclusion Criteria
Inability to informed consent”, cognitive impairment, ignorance of the German language
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaccination rate of chronically ill patients treated by general practitioners with or without diagnosed depression and/or anxiety disorders against seasonal influenza and/or Covid-19. The respective vaccination status is queried with the help of a paper-based questionnaire from the patient (patient reported outcome) and from the attending general practitioner before the start of the vaccination season against influenza/Covid-19 2022/2023. After the vaccination season against influenza/Covid-19 2022/2023 (from March 2023), the vaccination status will be queried a second and last time with the help of a paper-based questionnaire from the general practitioner.
- Secondary Outcome Measures
Name Time Method Survey and analysis of the influence of the doctor-patient relationship, self-management skills, and psychological factors influencing the patient's decision to receive vaccination against influenza and/or Covid-19.<br><br>This data will be queried with the help of a paper-based questionnaire from the patient (patient reported outcome) before the start of the vaccination season against influenza/Covid-19 2022/2023.